Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

1
Player Avatar EclecticRecluse (77.78) Submitted: 11/22/2010 7:31:11 AM : Underperform Start Price: $12.17 SVNT Score: +103.31

Extremely High Price for Book Value

Featured Broker Partners


Advertisement